ISTH Congress Abstracts

Official abstracts site for the ISTH Congress

MENU 
  • Home
  • Congress Archive
    • ISTH 2022 Congress
    • ISTH 2021 Congress
    • ISTH 2020 Congress
  • Resources
  • Search

ISTH 2021 Congress

July 17-21, 2021. Philadelphia, PA.

View by Title View by Number View Themes
Jump to:  View All • a b c d e f g h i j k l m n [o] p q r s t u v w x y z
  • Abstract Number: OC 62.3

    Obstetric Analgesia and Anaesthesia in Women with Inherited Bleeding Disorders

    O. Turan1, D. Kasapoglu2, Z. Abdi2, R. Abdul-Kadir1

  • Abstract Number: PB0665

    Off-label Use of Emicizumab in Persons with Acquired Hemophilia A and von Willebrand Disease: A Scoping Review of the Literature

    V. Mathew Thomas1, M.Y. Lim2

  • Abstract Number: PB0087

    Off-label Use of Prothrombin Complex Concentrate in the Clinical Practice of a Portuguese Tertiary Hospital

    D. Cibele1, S. Teixeira1, I. Machado1, L. Gonçalves1, C. Monteiro1, M. Carvalho1, M. Koch1

  • Abstract Number: PB0826

    Off-label Use of Thrombopoietin Receptor Agonists: Case Series and Review of the Literature

    M. Capecchi1, F. Serpenti2, J. Giannotta3, L. Pettine4, G. Reda4, W. Barcellini4, B. Fattizzo5, I. Martinelli6, A. Artoni6, F. Peyvandi7

  • Abstract Number: PB0639

    Off-pump Coronary Artery Bypass Graft Management in a Severe Hemophilia B Patient

    G. Barillari1, A. Poz1, A. Bertone1, M.E. Mosanghini1

  • Abstract Number: PB0123

    On the Diagnosis of Thrombinemia in the Arctic

    N. Vorobyeva1,2, A. Vorobyeva2

  • Abstract Number: PO135

    On the Issue of Thrombinemia in Moderate COVID-19

    N. Vorobyeva1,2, A. Barteneva2, I. Lovkova2

  • Abstract Number: PB0797

    Once a Day Compared to Twice a Day Enoxaparin in Children with Venous Thromboembolism: A Single Center Experience

    N. Montanez1, A. Gibson2, K. Addy1, S.S. Hashmi3, D. Brown1, N. Rodriguez1, N. Menon1, L. Srivaths1

  • Abstract Number: OC 63.3

    Optimization of Calf Pump Function Measurements by Venous Plethysmography for Prediction of Deep Vein Thrombosis

    D. Houghton1, A. Ashrani1, D. Liedl1, R. Mehta1, D. Hodge2, T. Rooke1, P. Wennberg1, W. Wysokinski1, R. McBane1

  • Abstract Number: PB0276

    Optimization of Operational Flow of D-dimer Test in a Core Laboratory in a Brazilian Tertiary Hospital to Ensure Operational Efficiency during the COVID-19 Pandemic

    J. Guerra1, V. Aranda1, C. Mendes1, A. Villarinho1, C. Monteiro1, R. Penteado1

  • Abstract Number: PB0459

    Optimization of Thrombin Generation for Hemophilia A

    T. van de Berg1, E. Beckers2, T. Hackeng1

  • Abstract Number: PB0102

    Optimizing Variant Curation Guidelines to Improve Clinical Genetic Testing for Hemophilia A and B

    K. Lee1, X. Chen2, Q. Ding3, K. Downes4, B. Doshi5, E.P. Ewen6, A. Frantz1, J. McCreery7, S. Mohan1, A. Payne8, X. Tian9, V. Trapp-Stamborski7, N.S. Key10, B.A. Konkle11, K. Gomez12

  • Abstract Number: PB1254

    Oral Anticoagulant Use in Patients with Morbid Obesity: A Systemic Review and Meta-analysis

    T.-F. Wang1, M. Carrier1, K. Fournier2, D. Siegal1, G. Le Gal1, A. Delluc1

  • Abstract Number: PB0254

    Oral Anticoagulation with Rivaroxaban as Thromboprophylaxis in Patients Recovered from COVID-19 Pneumonia in Veracruz, Mexico

    L. Del Carpio-Orantes1, S. García-Méndez1, J.S. Sánchez-Diaz1, K.G. Peniche-Moguel1, E.E. Aparicio-Sánchez1, O.I. Segura-Rodríguez1, A. Aguilar-Silva1, O. García-Hernández1, A. Escobar-Huerta1, A. Ahumada-Zamudio1, A.R. Velasco-Caicero1, O. González-Segovia1, E.J. Pacheco-Pérez1, A.E. Munguia-Sereno1, E.R. Contreras-Sánchez1, S.N. Hernández-Hernández1, L.J. Medrano-Rios1, A.L. Rosas-Lozano1

  • Abstract Number: OC 38.2

    Oral Delivery of Factor VIII Reduces the Magnitude of the Anti-FVIII Immune Response and Increases Splenic Treg Numbers

    T. Afrin1, C. Hough1, D. Lillicrap1

  • Abstract Number: OC 59.1

    Oral Pazopanib Results in Durable Hemostasis in Patients with Severe Bleeding and RBC Transfusion-dependent Hereditary Hemorrhagic Telangiectasia

    J. Parambil1, J. Gossage2, K. McCrae1, T. Woodard1, K.N. Menon1, K. Timmerman1, D. Pederson1, D. Sprecher3, H. Al-Samkari4,5

  • Abstract Number: OC 48.4

    Orally Delivered Factor VIII Restores Hemostasis in a Hemophilia A Dog

    M.A. Hashim1, A. Yamaguchi1, A.T. Vo1, A.K. Dhalla1, B. Syed1, L.C. Fung1, V. Salgotra1, A. Dasari1, G. Schrenk2, O. Zoechling2, D. Sexton3, G. Allen3, C.T. Long4, E.P. Merricks4, M. Imran1, T.C. Nichols4

  • Abstract Number: OC 44.4

    Origin of Antiphospholipid Antibodies in Autoimmunity and Viral Infection

    N. Müller-Calleja1, A. Hollerbach1, N. Lemmermann2, W. Ruf3, K. Lackner1

  • Abstract Number: LPB0089

    Outcome of Cancer-associated Venous Thromboembolism Is More Favourable among Patients with Hematologic Malignancies than with Solid Tumors

    R. Lecumberri1, P. Ruiz-Artacho2, I. Tzoran3, B. Brenner3, D. Farge-Bancel4, V. Rosa5, I. Francisco6, L. Hernández-Blasco7, J. Trujillo-Santos8, M. Monreal9, RIETE Investigators

  • Abstract Number: OC 25.4

    Outcomes Associated with Mandatory Venous Thromboembolism (VTE) Risk Assessment in General Obstetric and Gynecologic Patients

    S. Sharma1, C. Brown1, J. Neeluru2, S. Vijan3, M. Moote4, P. Henke5, N. Osborne5, A. Obi5

  • Abstract Number: PB0695

    Outcomes of a Bleeding Disorders Diagnostic Multi-disciplinary Team Meeting for Diagnosing Unclassified Bleeding Disorder / Bleeding of Unknown Cause

    W. Thomas1, M. Ali1, A. Arora2, J. Prabhakaran2, K. Abu-Zeinah2, D. White1, S. MacDonald1, E. Symington1.

  • Abstract Number: PB1236

    Outcomes of Non-bleeding Patients on Warfarin with an INR > 10, who Received Vitamin K or Conservative Therapy

    A. Jones1, S. Vazquez2, G. Barnes3, C. Anderson4, S. Woller4, S. Stevens4, N. Clark5, T. Delate6, M. Crowthrm7, D. Witt8

  • Abstract Number: PB0788

    Outcomes of Prophylactic Enoxaparin against Venous Thromboembolism in Hospitalized Children

    E. Bennett1, C. Delgado Corcoran2, C. Heyrend2, R. Wilcox2, C. Pannucci3, V. Faustino4

  • Abstract Number: OC 53.3

    Outcomes of Subsequent Pregnancy in Women with a History of Immune Thrombotic Thrombocytopenic Purpura

    J. Brown1, S. Hussain2, M. Mazepa3, A. Moliterno2, S. Chaturvedi2

  • Abstract Number: PB1307

    Outcomes of Treatment of Thromboembolic Disease during Pregnancy and Postpartum – Single-center Experience

    Š. Stražišar1, M. Kozak1

  • Abstract Number: PB0308

    Overall Haemostatic Potential Assay Can Detect Hypercoagulability and Hypofibrinolysis in Anticoagulated Patients Following Venous Thromboembolism

    J. Wang1,2, P. Ho1,2,3

  • Abstract Number: OC 45.3

    Overt DIC Score Predicts Mortality in Liver Insufficiency, a Comparison with the MELD-Na Score

    J. Grafeneder1,2, N. Buchtele3, D. Egger1, M. Schwameis2, C. Ay4, B. Jilma1, C. Schörgenhofer1

Jump to:  View All • a b c d e f g h i j k l m n [o] p q r s t u v w x y z
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2022 John Wiley & Sons, Inc. All Rights Reserved.
Wiley